Reply to Liu et al., Zhou et al., and Dong et al.
Saved in:
| Title: | Reply to Liu et al., Zhou et al., and Dong et al. |
|---|---|
| Authors: | Sadatsafavi M; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Tran TN; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, United States., Scelo G; Observational and Pragmatic Research Institute, Singapore, Singapore.; Optimum Patient Care Global, Cambridge, United Kingdom., Price DB; Observational and Pragmatic Research Institute, Singapore, Singapore.; Optimum Patient Care Global, Cambridge, United Kingdom.; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. |
| Corporate Authors: | all authors of “Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated With Biologics” |
| Source: | American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2026 Mar 01; Vol. 212 (3), pp. 673-674. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-4970 |
|---|---|
| DOI: | 10.1164/rccm.202508-1914LE |
